Your browser doesn't support javascript.
loading
Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.
Martin, M A; Klein, T E; Dong, B J; Pirmohamed, M; Haas, D W; Kroetz, D L.
Affiliation
  • Martin MA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA.
Clin Pharmacol Ther ; 91(4): 734-8, 2012 Apr.
Article in En | MEDLINE | ID: mdl-22378157
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Dideoxynucleosides / HLA-B Antigens / Reverse Transcriptase Inhibitors / Genotype Type of study: Guideline Limits: Animals / Humans Language: En Journal: Clin Pharmacol Ther Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Dideoxynucleosides / HLA-B Antigens / Reverse Transcriptase Inhibitors / Genotype Type of study: Guideline Limits: Animals / Humans Language: En Journal: Clin Pharmacol Ther Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States